Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.

Date publication

juin 2015

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe , Pr GANGI Afshin , Pr NAMER Izzie-Jacques

Tous les auteurs :
Imperiale A, Garnon J, Bachellier P, Gangi A, Namer IJ

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/25706791

Résumé

PET/CT-guided biopsy may be useful to confirm the metabolic findings when conventional imaging fails to show morphological abnormalities. Herein, we report the results of simultaneous F-FDOPA (fluorodihydroxyphenylalanine) PET/CT-guided biopsy and RFA (radiofrequency ablation) in 1 patient with hepatic metastatic evolution of a well-differentiated ileal neuroendocrine tumor. Beyond FDG, FDOPA could be successfully recommended in patients with neuroendocrine tumor for planning PET/CT-guided diagnostic biopsy, ablative treatment, and immediate efficacy assessment in a 1-step examination.

Référence

Clin Nucl Med. 2015 Jun;40(6):e334-5